Cargando…

Prognostic Value of Sarcopenia and Metabolic Parameters of (18)F-FDG-PET/CT in Patients with Advanced Gastroesophageal Cancer

We investigated the prognostic value of sarcopenia measurements and metabolic parameters of primary tumors derived from (18)F-FDG-PET/CT among patients with primary, metastatic esophageal and gastroesophageal cancer. A total of 128 patients (26 females; 102 males; mean age 63.5 ± 11.7 years; age ran...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hinzpeter, Ricarda, Mirshahvalad, Seyed Ali, Kulanthaivelu, Roshini, Murad, Vanessa, Ortega, Claudia, Metser, Ur, Liu, Zhihui Amy, Elimova, Elena, Wong, Rebecca K. S., Yeung, Jonathan, Jang, Raymond W., Veit-Haibach, Patrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10001050/ https://www.ncbi.nlm.nih.gov/pubmed/36899982 http://dx.doi.org/10.3390/diagnostics13050838

Ejemplares similares

Prognostic Value of [18F]-FDG PET/CT Radiomics Combined with Sarcopenia Status among Patients with Advanced Gastroesophageal Cancer
por: Hinzpeter, Ricarda, et al.
Publicado: (2022)

Standardized classification schemes in reporting oncologic PET/CT
por: Murad, Vanessa, et al.
Publicado: (2023)

Corrigendum: Standardized classification schemes in reporting oncologic PET/CT
por: Murad, Vanessa, et al.
Publicado: (2023)

Impact of the COVID-19 Pandemic on Staging Oncologic PET/CT Imaging and Patient Outcome in a Public Healthcare Context: Overview and Follow Up of the First Two Years of the Pandemic
por: Kohan, Andres, et al.
Publicado: (2023)

Disparity and Diversity in NSCLC Imaging and Genomics: Evaluation of a Mature, Multicenter Database
por: Kohan, Andres, et al.
Publicado: (2023)

Prognostic value of PET/CT and MR-based baseline radiomics among patients with non-metastatic nasopharyngeal carcinoma
por: Kulanthaivelu, Roshini, et al.
Publicado: (2022)

CT Radiomics and Whole Genome Sequencing in Patients with Pancreatic Ductal Adenocarcinoma: Predictive Radiogenomics Modeling
por: Hinzpeter, Ricarda, et al.
Publicado: (2022)

Combination of FDG PET/CT Radiomics and Clinical Parameters for Outcome Prediction in Patients with Hodgkin’s Lymphoma
por: Ortega, Claudia, et al.
Publicado: (2023)

(18)F-DCFPyL PET/CT in advanced high-grade epithelial ovarian cancer: A prospective pilot study
por: Metser, Ur, et al.
Publicado: (2022)

Convolutional neural networks for improving image quality with noisy PET data
por: Schaefferkoetter, Josh, et al.
Publicado: (2020)

(18)F-DCFPyL (PSMA) PET in the Management of Men with Biochemical Failure after Primary Therapy: Initial Clinical Experience of an Academic Cancer Center
por: Metser, Ur, et al.
Publicado: (2021)

Combined simultaneous FDG-PET/MRI with T1 and T2 mapping as an imaging biomarker for the diagnosis and prognosis of suspected cardiac sarcoidosis
por: Cheung, Edward, et al.
Publicado: (2021)

Impact of Sites of Metastatic Dissemination on Survival in Advanced Gastroesophageal Adenocarcinoma
por: Wang, Xin, et al.
Publicado: (2022)

Combination of clinical, radiomic, and “delta” radiomic features in survival prediction of metastatic gastroesophageal adenocarcinoma
por: Krishna, Satheesh, et al.
Publicado: (2023)

Diagnostic performance of FDG-PET/MRI and WB-DW-MRI in the evaluation of lymphoma: a prospective comparison to standard FDG-PET/CT
por: Herrmann, Ken, et al.
Publicado: (2015)

Nasopharyngeal Carcinoma Radiomic Evaluation with Serial PET/CT: Exploring Features Predictive of Survival in Patients with Long-Term Follow-Up
por: Dmytriw, Adam A., et al.
Publicado: (2022)

Respiratory and cardiac motion correction in positron emission tomography using elastic motion approach for simultaneous abdomen and thorax positron emission tomography-magnetic resonance imaging
por: Farag, Adam, et al.
Publicado: (2023)

Oligometastasis in Prostate Cancer: Can We Learn from Those “Excluded” from a Phase 2 Trial?
por: Glicksman, Rachel M., et al.
Publicado: (2023)

Intra-individual comparison of PET/CT with different body weight-adapted FDG dosage regimens
por: Geismar, Jan H, et al.
Publicado: (2015)

FDG-PET parameters predict for recurrence in anal cancer – results from a prospective, multicentre clinical trial
por: Jones, Michael Peter, et al.
Publicado: (2019)

Impact of [(18)F]FDG PET/CT in the Assessment of Immunotherapy-Induced Arterial Wall Inflammation in Melanoma Patients Receiving Immune Checkpoint Inhibitors
por: Ranjbar, Shaghayegh, et al.
Publicado: (2023)

Association of Esophageal Inflammation, Obesity and Gastroesophageal Reflux Disease: From FDG PET/CT Perspective
por: Wu, Yen-Wen, et al.
Publicado: (2014)

(18)FDG-PET-CT identifies histopathological non-responders after neoadjuvant chemotherapy in locally advanced gastric and cardia cancer: cohort study
por: Schneider, Paul M., et al.
Publicado: (2018)

International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology
por: Veit-Haibach, Patrick, et al.
Publicado: (2023)

Dynamic comparison of PET imaging performance between state-of-the-art ToF-PET/CT and ToF-PET/MR scanners
por: Delso, Gaspar, et al.
Publicado: (2014)

EANM/SNMMI practice guideline for [(18)F]FDG PET/CT external beam radiotherapy treatment planning in uterine cervical cancer v1.0
por: Adam, Judit A., et al.
Publicado: (2020)

The impact of atlas-based MR attenuation correction on the diagnosis of FDG-PET/MR for Alzheimer’s diseases— A simulation study combining multi-center data and ADNI-data
por: Sekine, Tetsuro, et al.
Publicado: (2020)

Clinical evaluation of PET image quality as a function of acquisition time in a new TOF-PET/MR compared to TOF-PET/CT - initial results
por: Zeimpekis, Konstantinos, et al.
Publicado: (2015)

Establishing a Provincial Registry for Recurrent Prostate Cancer: Providing Access to PSMA PET/CT in Ontario, Canada
por: Young, Sympascho, et al.
Publicado: (2021)

PET/CT versus body coil PET/MRI: how low can you go?
por: Appenzeller, P., et al.
Publicado: (2013)

Clinical image quality perception and its relation to NECR measurements in PET
por: Queiroz, Marcelo A, et al.
Publicado: (2014)

The Role and Limitations of 18-Fluoro-2-deoxy-d-glucose Positron Emission Tomography (FDG-PET) Scan and Computerized Tomography (CT) in Restaging Patients with Hepatic Colorectal Metastases Following Neoadjuvant Chemotherapy: Comparison with Operative and Pathological Findings
por: Lubezky, Nir, et al.
Publicado: (2007)

FDG-PET in lymphoma
por: Meignan, Michel
Publicado: (2014)

PET-FDG: Impetus
por: Nanni, Cristina
Publicado: (2020)

Dose Optimization in TOF-PET/MR Compared to TOF-PET/CT
por: Queiroz, Marcelo A., et al.
Publicado: (2015)

EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies
por: Aide, Nicolas, et al.
Publicado: (2017)

Sarcopenia as a prognostic factor for survival in patients with locally advanced gastroesophageal adenocarcinoma
por: Koch, Christine, et al.
Publicado: (2019)

Preliminary evaluation of image quality in a new clinical ToF-PET/MR scanner
por: Delso, Gaspar, et al.
Publicado: (2014)

FDG-PET and PET/CT - Part II
por: Takalkar, Amol M, et al.
Publicado: (2008)

Cluster-based segmentation of dual-echo ultra-short echo time images for PET/MR bone localization
por: Delso, Gaspar, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7ppmvqkg5g29o17mbavkk4vkrj